Corneal Collagen Cross-Linking (CXL) is an established medical procedure designed to strengthen the cornea and halt the progression of diseases associated with its thinning and deformation—most commonly keratoconus. The method is based on a photochemical reaction between riboflavin (vitamin B2) and ultraviolet light (UV-A), which leads to the formation of additional collagen cross-links within the stroma.
What is the procedure
The procedure combines riboflavin installation into the cornea and controlled UV-A irradiation (wavelength 365–370 nm). This causes an increase in cross-links between collagen fibrils. The result is increased biomechanical stability of the cornea and a reduced risk of further ectasia.
Corneal cross-linking - when is it recommended
The primary indication is proven or strongly suspected keratoconus progression. Progression is determined by:
- increase in maximum keratometry (Kmax),
- increasing astigmatism,
- reduction in minimum pachymetry,
- changes in corneal topography and tomography.
The procedure also applies to:
- post-LASIK or post-PRK ectasia,
- keratoectasia of other origin,
- in some cases as a combined method for refractive improvement (PRK + CXL).
The earlier crosslinking is performed for progressive keratoconus, the better the prognosis for stabilization.
Types of corneal cross-linking
- Standard Epi-off (Dresden protocol)
- Epithelial removal.
- Riboflavin accumulation for ~30 minutes.
- UV-A irradiation 3 mW/cm² for 30 minutes.
- Best researched and with the highest proven effectiveness.
- Accelerated (CXL)
- Also epi-off, but with higher UV power (9–30 mW/cm²) for a shorter time.
- Reduces duration without significant loss of efficiency.
- Transepithelial / epi-on CXL
- The epithelium is preserved.
- Special permeable riboflavin formulations are used.
- Faster recovery and less discomfort.
- Suitable for early stages or patients intolerant to epi-off.
- Pulsed CXL
- UV-A light is pulsed to optimize oxygen availability.
- Goal: more efficient photochemical reaction.
- Topography-guided (Customized CXL)
- The radiation is individualized according to the corneal map.
- Useful for asymmetric and localized forms of keratoconus.
- Combined PRK + CXL (Athens protocol)
- Mild superficial laser ablation for visual acuity improvement.
- Followed by crosslinking for stabilization.
- Suitable for mild to moderate forms and sufficient corneal thickness.
Which patients are suitable
Corneal cross-linking is suitable for patients who are diagnosed with:
- Keratoconus progression (especially between the ages of 12–35),
- minimum corneal thickness ≥ 400 μm after riboflavin saturation,
- Good general ocular status, suitable for photochemotherapy.
Patients with excessively thin corneas, active infections, severe scarring, or autoimmune diseases are evaluated on a strictly individual basis.
Recovery and Expected Outcomes After Corneal Cross-linking
After a standard epi-off:
- discomfort 2–4 days,
- corneal stabilization in the following months,
- It is possible to slightly improve visual acuity.
With epi-on recovery is faster, but the effect is less pronounced.
Corneal cross-linking is a key procedure for stopping the progression of keratoconus and other corneal ectasias. It offers reliable, long-term stabilization and protects the patient from progressive vision deterioration and the need for future corneal transplantation. The choice of a specific protocol is based on the anatomical characteristics of the cornea, the stage of the disease, and the individual characteristics of the patient.
Frequently Asked Questions About Corneal Cross-linking
-
Is the procedure painful?
During the procedure itself, no pain is felt thanks to local anesthesia. After standard epi-off crosslinking, discomfort, burning, or a sandy sensation in the eye is normal for the first 2-4 days. With epi-on, the discomfort is significantly milder.
-
Will I see better after cross-linking?
The primary goal of the procedure is stabilization, not vision improvement. In many patients, vision remains the same, and in some, slight improvement is observed in the following months due to the gradual equalization of the cornea. If the goal is vision correction, a combined PRK + CXL can be discussed.
-
Will a repeat procedure be necessary?
Most patients only require a single cross-linking treatment. Retreatment is only considered if there is evidence of new progression years later – a relatively rare occurrence. Regular follow-ups with an ophthalmologist are crucial for timely detection of changes.
-
How long does the procedure itself take?
Depending on the type of crosslinking—standard epi-off takes about 45–60 minutes, while accelerated protocols are shorter (10–20 minutes).
-
When can I return to my normal activities?
After epi-off, most patients return to their daily activities within 3–5 days. With epi-on, recovery is faster, and it is often possible as soon as the next day.
-
Can I wear contact lenses after the procedure?
Contact lenses should be avoided until the epithelium is fully healed. This is usually 7–10 days for epi-off, and shorter for epi-on. The doctor determines the exact time.
-
Is there a risk of complications?
Cross-linking is a safe procedure with low risk. Possible but rare complications include infection, corneal clouding, delayed healing, or temporary vision changes. Following instructions significantly reduces risk.
-
How long does the effect of cross-linking last?
The effect is long-term. Studies show stable results for over 10–15 years. In young patients, regular monitoring is recommended because the disease can be more aggressive in them.
-
Can cross-linking cure keratoconus?
No, it doesn't cure, but stabilizes the disease. That's its main purpose, and that's precisely why it's most effective when done on time.
The coordinators at ZITS “Medical Karadji“ can provide patients with a connection to leading ophthalmologists, specialists in the treatment of keratoconus and the application of corneal cross-linking. Contact us for more information and professional guidance.
